Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Goodwill & Intangibles (2018 - 2023)

NovaBridge Biosciences (NBP) has 6 years of Goodwill & Intangibles data on record, last reported at $16.4 million in Q4 2023.

  • On a quarterly basis, Goodwill & Intangibles fell 58.55% to $16.4 million in Q4 2023 year-over-year; TTM through Dec 2023 was $16.4 million, a 58.55% decrease, with the full-year FY2023 number at $16.7 million, down 99.96% from a year prior.
  • Goodwill & Intangibles reached $16.4 million in Q4 2023 per NBP's latest filing, down from $40.1 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for NBP hit a ceiling of $44.1 billion in Q4 2021 and a floor of $16.4 million in Q4 2023.
  • A 5-year average of $4.5 billion and a median of $42.7 million in 2020 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: soared 103270.82% in 2021, then crashed 99.91% in 2022.
  • Tracing NBP's Goodwill & Intangibles over 5 years: stood at $44.2 million in 2019, then dropped by 3.35% to $42.7 million in 2020, then skyrocketed by 103270.82% to $44.1 billion in 2021, then crashed by 99.91% to $39.6 million in 2022, then crashed by 58.55% to $16.4 million in 2023.
  • Business Quant data shows Goodwill & Intangibles for NBP at $16.4 million in Q4 2023, $40.1 million in Q2 2023, and $39.6 million in Q4 2022.